01 July 1997
Acute renal failure in children and its long-term follow-up treatmentMaria Miler
Med Sci Monit 1997; 3(4): HY563-572 :: ID: 501446
Acute renal failure (ARF) is a state that endangers the life of patients. The patient outcome is dependant upon on many factors such as: patient age, the cause of renal failure, the degree of demage to the parenchyma, the methods and the speed of treatment, and many factors not always known.Tests on finding a relationship between certain factors and the prognosis have not proved successful. Not much is known about the long-term follow-up of ARF in children who have survived the acute phase of the disease. The analysis incorporated 118 children. Their ages ranged from 3 days postpartum to 5 years. All subjects were diagnosed with acute renal failure. The analysis was conducted on children by taking an initial patient history and then by follow-up out-patient control.It was determined that ARF had the highest percentage of occurrence in infants, with males having a higher rate of occurrence. The most commonly observed cause of ARF was hypovolemia, associated mostly with either diarrhea or with hemolytic-uremic syndrom (HUS). It was determined that a failure in the urinary system beyond the kidneys (post-renal) occurred only during the first year of life. Beyond that time, the nephrotic syndrom was most commonlyu observed with ARF. There was no concrete evidence for any relationship between a patient's age, the cause of ARF, and the developement of the acute phase of the illness. Severe cases of ARF (according to Giananton's criterium) dominated in the 2 year old age group and were not observed in patients above 3 years of age. It was determined that this form of ARF occured only in patients with HUS. It was shown that treatment by dialysis was most often associated with the advanced acute phase. In this study 33.9% of the sample group were treated with dialysis.
Keywords: acute renal failure, children, long-term follow-up treatment
01 May 2023 : EditorialEditorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor Therapy
Med Sci Monit 2023; 29:e940911
31 May 2023 : Review articlePrevalence, Diagnosis, and Management of Eclampsia and the Need for Improved Maternal Care: A Review
Med Sci Monit In Press; DOI: 10.12659/MSM.939919
30 May 2023 : Clinical ResearchA Case-Control Study of Cognitive Function in Patients with End-Stage Renal Disease Before and After Hemodi...
Med Sci Monit In Press; DOI: 10.12659/MSM.940409
30 May 2023 : Review articleA Review of the Role of the Zebrafish (Danio reiro) in Preclinical and Clinical Models of Biomarker Identif...
Med Sci Monit In Press; DOI: 10.12659/MSM.940550
30 May 2023 : Database AnalysisThe COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in Poland
Med Sci Monit In Press; DOI: 10.12659/MSM.940904
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : EditorialEditorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...
Med Sci Monit 2022; 28:e935952